Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
α-Bungarotoxin for Nicotinic Receptor Blockade
2026-10-01
Use α-Bungarotoxin to convert α7 receptor involvement from a correlation into a testable pharmacological hypothesis. This workflow connects receptor blockade with cholinergic signaling, necroptosis, inflammation, and trophoblast function while providing practical controls for neuroscience and translational assays.
-
TH287 MTH1 Inhibitor for Radiosensitization
2026-10-01
TH287 converts MTH1-dependent nucleotide sanitization into a controllable cancer-cell stress model, with particular value in ionizing-radiation studies. A timing-focused workflow helps researchers examine oxidative DNA damage, apoptosis, cell-cycle arrest, and radiosensitization in castration-resistant prostate cancer models.
-
Bestatin, Actinonin, and Intracellular Myeloma Effects
2026-09-30
The reference study challenges the assumption that bestatin and actinonin inhibit proliferation mainly by blocking cell-surface aminopeptidases. By combining proliferation assays with efflux-modifier experiments, it supports a model in which intracellular drug exposure and transporter activity are central determinants of response.
-
Fingolimod (FTY720) in T-Cell Trafficking Assays
2026-09-30
Fingolimod (FTY720) provides a controllable way to interrogate S1P-dependent lymphocyte trafficking alongside magnetically guided CAR-T-mimicking cell platforms. This workflow-focused guide separates egress inhibition, T-cell activation, tumor-cell toxicity, and CNS signaling so combination experiments remain interpretable rather than assuming improved tumor infiltration.
-
Ampicillin Sodium: Mechanism and Research Use
2026-09-29
Ampicillin sodium is a β-lactam antibiotic used to study bacterial cell wall biosynthesis inhibition and antibacterial activity. The A2510 product is reported at 98% purity, with product-dossier benchmarks of 1.8 μg/mL against transpeptidase in E. coli 146 cells and a 3.1 μg/mL MIC.
-
Benzyl-activated Streptavidin Magnetic Beads
2026-09-29
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide magnet-assisted capture of biotinylated proteins, peptides, antibodies, oligonucleotides, nucleic acids, and related targets from complex samples. They are not intended for direct capture of non-biotinylated targets, and preservative or BSA carryover must be controlled when samples are used for live-cell, enzymatic, or highly sensitive analytical workflows.
-
HyperScript™ Reverse Transcriptase for Translational qPCR
2026-09-28
A mechanistic and strategic guide to selecting reverse transcriptase chemistry for structured RNA, scarce templates, and translational qPCR workflows—anchored in recent Moloney murine leukemia virus assay research.
-
Thiazovivin: Practical ROCK Inhibitor Workflow
2026-09-28
Thiazovivin is a ROCK inhibitor used to support fibroblast reprogramming during induced pluripotent stem cell generation and human embryonic stem cell survival after trypsinization. It is intended for controlled research workflows, not diagnostic, medical, or clinical use; the product dossier does not provide a working concentration or a directly matched paper dataset.
-
ECL Chemiluminescent Substrate Detection Kit for OSCC
2026-09-27
Translate evidence on CAF-derived fatty acids and oral cancer signaling into a practical Western blot plan for targets such as caveolin-1 and PI3K/AKT pathway proteins. The hypersensitive HRP substrate supports low-picogram-range detection, reduced background, and a longer imaging window for carefully optimized immunoblots.
-
Cy5 Maleimide for α-Synuclein Condensate Imaging
2026-09-26
Use Cy5 maleimide to create a site-specific red fluorescent probe for tracking cysteine-engineered α-synuclein in condensate assays. A controlled labeling workflow helps distinguish genuine electrostatic partitioning from changes introduced by the dye, protein construct, or solvent.
-
REV1–DHX36 Coordinates G-Quadruplex Replication
2026-09-25
A 2026 study shows that REV1 directly engages the G-quadruplex helicase DHX36, linking G4 unwinding to control of replication-associated single-stranded DNA gaps. The findings position REV1 as a coordinator of fork progression, mutagenesis, and cellular responses to G4 stabilization, while leaving open how these mechanisms translate to therapeutic settings.
-
GSK126: An EZH2 Inhibitor for Mechanistic Studies
2026-09-25
Use GSK126 to test whether EZH2 catalytic activity contributes to a phenotype, then pair pharmacological inhibition with genetic perturbation and H3K27me3 readouts. A study of oxidant-stressed endothelial cells offers a practical model for extending this approach beyond oncology—while also showing why cross-domain conclusions need careful validation.
-
TH287: MTH1 Inhibition and CRPC Radiosensitization
2026-09-24
TH287 is a potent MTH1 inhibitor used to investigate oxidized nucleotide handling and cancer-cell responses to DNA damage. In PC-3 and DU-145 castration-resistant prostate cancer models, a 2026 study reported greater cell killing with TH287 plus ionizing radiation than with either treatment alone, with the strongest effect when radiation was delivered 12 hours after drug treatment began.
-
Pulmonary Risedronate–Vitamin D3 Dendrimers
2026-09-24
This study tested PAMAM-G5 dendrimers as a pulmonary co-delivery platform for risedronate sodium and vitamin D3, aiming to bypass limitations of oral dosing. In an osteoporosis rat model, inhaled treatment improved serum mineral measures and bone mineral density over 21 days, with molecular and metabolomic results implicating WNT signaling in disease progression and response.
-
Bestatin and Actinonin Act Through Intracellular Effects
2026-09-23
Grujić and Renko found that bestatin and actinonin suppress proliferation of U937 and K562 cells in a manner not explained mainly by inhibition of cell-surface aminopeptidases. Efflux-modifier experiments support an intracellular component to their activity, and show that transporter effects can complicate interpretation of antiproliferative assays.